Takada S, Obinata M
Faculty of Pharmaceutical Sciences, University of Tokyo, Japan.
Cell Differ. 1987 Jul;21(2):111-8. doi: 10.1016/0045-6039(87)90418-0.
A beta-globin/TK fusion gene was microinjected into non-erythroid cells (Ltk- cells) and erythroid cells (murine erythroleukemia (MEL) cells), and the interactions of the regulatory cellular factors with the beta-globin sequences were investigated by the in vivo competition experiment. The fusion gene was expressed efficiently in Ltk- cells. This expression was inhibited by a co-injection with a three-fold molar excess of the 5'-flanking sequence of the beta-globin gene or with a nine-fold molar excess of the mammary tumor virus LTR, but not with the alpha-globin gene. The fusion gene was expressed very poorly in the uninduced MEL cells and highly in the induced MEL cells. The co-injection of the beta-globin gene did not affect expression in the MEL cells in either uninduced or induced conditions.
将一个β-珠蛋白/TK融合基因显微注射到非红系细胞(Ltk-细胞)和红系细胞(小鼠红白血病(MEL)细胞)中,通过体内竞争实验研究调节性细胞因子与β-珠蛋白序列的相互作用。该融合基因在Ltk-细胞中高效表达。与三倍摩尔过量的β-珠蛋白基因5'-侧翼序列或九倍摩尔过量的乳腺肿瘤病毒LTR共注射可抑制这种表达,但与α-珠蛋白基因共注射则无此作用。该融合基因在未诱导的MEL细胞中表达很差,而在诱导的MEL细胞中高表达。在未诱导或诱导条件下,共注射β-珠蛋白基因均不影响MEL细胞中的表达。